Author/Authors :
Karivedu, Vidhya Department of Internal Medicine - Division of Hematology/Oncology - University of Cincinnati College of Medicine - Cincinnati - OH, USA , Eldessouki, Ihab Department of Internal Medicine - Division of Hematology/Oncology - University of Cincinnati College of Medicine - Cincinnati - OH, USA , Taftaf, Ahmad Department of Internal Medicine - Division of Hematology/Oncology - University of Cincinnati College of Medicine - Cincinnati - OH, USA , Correa, Zelia Ocular Oncology Service - Department of Ophthalmology - University of Cincinnati College of Medicine, USA , Zhu, Zheng Department of Biostatistics and Bioinformatics - Department of Environmental Health - College of Medicine - University of Cincinnati - Cincinnati - OH, USA , Makramalla, Abouelmagd Division of Vascular and Interventional Radiology - University of Cincinnati College of Medicine - Cincinnati - OH, USA , Karim, Nagla Abdel Department of Internal Medicine - Division of Hematology/Oncology - Medical College of Georgia-Augusta University - Augusta - GA, USA
Keywords :
Corrigendum , Nivolumab , Ipilimumab , Treatment , Metastatic Uveal Melanoma , Single-Center Experience
